Cell Death Assays: An Overview of Common Techniques

Cell death assays are laboratory techniques used to measure whether, how, and how many cells are dying in a sample. They range from simple dye tests that take minutes to sophisticated imaging platforms that track individual cells in real time over days. No single assay captures the full picture, because “cell death” is not one event. Cells can die through orderly self-destruction, through catastrophic membrane rupture, or through a growing list of regulated pathways that blur the line between the two. The assay you pick determines what kind of death you can see and what kinds you miss entirely.

Why There Are So Many Ways to Measure Cell Death

Cell death was historically sorted into broad buckets based on what it looked like under a microscope: apoptosis (cells shrinking and breaking into tidy packages), necrosis (cells swelling and bursting), and autophagy-related death (cells digesting their own contents). An international panel called the Nomenclature Committee on Cell Death pointed out that these visual categories often got used without reference to the actual biochemical processes underneath, leading to confusion across the field.¹ The committee later pushed for definitions based on measurable molecular features rather than appearance alone.²

This shift matters for assay choice. A test that only checks whether the cell membrane is intact will lump every form of necrotic-looking death into one category. A test that detects a specific enzyme will catch one pathway and miss others. Researchers today usually combine multiple assays to figure out not just how much death is happening but which type.

Membrane Integrity Assays

The oldest and simplest strategy is to ask: is the cell’s outer membrane still intact? Living cells keep certain dyes out. Dead cells, whose membranes have holes, let dyes in. Two of the most widely used membrane-integrity techniques are trypan blue exclusion and the LDH release assay.

Trypan Blue Exclusion

Trypan blue is a large dye molecule that cannot cross an intact cell membrane. You mix your cells with the dye, look under a regular light microscope, and count. Cells with clear cytoplasm are alive; cells that turn blue are dead.³ It is cheap, fast, and requires no special equipment beyond a microscope and a counting chamber.

The drawbacks are real, though. The dye can seep into living cells if you leave it on too long, and manual counting introduces variability depending on the person doing it.⁴ Automated cell counters help with consistency, and flow cytometry adaptations of the technique reduce operator bias, but in many labs the hemocytometer-and-eyeball version remains the default quick check.

LDH Release

Lactate dehydrogenase (LDH) is an enzyme normally trapped inside cells. When a cell’s membrane breaks down, LDH leaks out into the surrounding culture medium. You can then measure it with a simple colorimetric reaction in a plate reader. Because the enzyme is stable in culture medium, the signal is reliable and proportional to the amount of damage.⁵

LDH release is especially useful for toxicity screens because you do not need to disturb the cells. You just sample the medium. The limitation is that it tells you cells have died but says nothing about how. Apoptosis in its later stages can also release LDH once secondary necrosis sets in, so a high LDH reading does not necessarily mean the death was necrotic from the start.

Metabolic Activity Assays

Instead of asking whether the membrane is intact, metabolic assays ask whether the cell’s internal machinery is running. Living cells maintain active metabolism; dead or dying cells do not. The most popular versions rely on chemical reagents that change color or fluorescence when reduced by metabolically active cells.

MTT and Its Relatives

MTT is a yellow compound that crosses into cells and gets reduced by metabolic enzymes, forming a violet-blue crystal called formazan. The more living cells you have, the more formazan accumulates, and you measure the color intensity with a plate reader.⁶ Related assays (MTS, XTT, WST-1) work on the same principle but produce soluble products, skipping the crystal-dissolving step that MTT requires.

The MTT assay has a well-known blind spot in drug-screening work. Some anti-cancer drugs cause surviving cells to ramp up their mitochondrial content, which inflates the formazan signal per cell. One study found that per-cell metabolic activity increased by roughly 1.2 to 3.3 times after drug treatment in lung and cervical cancer cell lines, driven by a corresponding increase in mitochondrial mass. The result was that the MTT reading showed no significant difference from untreated controls even though the actual cell count had dropped.⁷ If you are screening drugs for cytotoxicity, this artifact can lead to the wrong conclusion about whether a compound is working.

Resazurin (Alamar Blue)

Resazurin is a weakly fluorescent blue dye that living cells convert into resorufin, which glows bright pink-red under a fluorescence reader.⁸ Unlike MTT, resazurin is non-toxic to cells at working concentrations, which means you can measure viability at multiple time points from the same well without killing the culture. Standardized protocols for optimizing the assay in different cell types have been published to improve reproducibility across labs.⁹

Its main advantage over MTT-type assays is flexibility: you add the reagent, incubate, read fluorescence, then continue culturing. Its main disadvantage is shared with all metabolic assays. It measures metabolic rate, not cell number, and anything that changes metabolism without killing the cell (or kills the cell without immediately shutting down metabolism) will skew the result.

ATP-Based Luminescent Assays

ATP is the energy currency of living cells, and its levels drop rapidly once a cell dies. Luminescent assays use an enzyme called luciferase (the same family of proteins that makes fireflies glow) to convert ATP into light. The more ATP present, the brighter the signal, giving you a direct readout of how many viable cells remain.

In head-to-head comparisons, ATP-based assays tend to outperform both trypan blue and tetrazolium-based assays (like XTT) for detecting acute drug-induced cytotoxicity. One study testing anti-cancer compounds on liver cancer cells found that the ATP assay was the most sensitive of the three under the conditions tested, while XTT failed to detect acute toxicity from two of the drugs entirely.¹⁰ A systematic comparison in glioma stem-like cells similarly found that ATP luminescence produced smaller standard deviations and more specific readouts than NADH-based alternatives.¹¹

The format also scales well. ATP assays have been adapted into 384-well plates for high-throughput screening of drug libraries, including anti-parasitic compound screening against organisms like trypanosomes.¹² The trade-off is that luminescent assays destroy the sample. Once you lyse the cells to release ATP, you cannot go back and run a second assay on the same well.

Apoptosis-Specific Detection

The assays above measure death in bulk, without distinguishing how cells are dying. When researchers need to know whether cells are undergoing apoptosis specifically, they turn to assays that detect the molecular hallmarks of programmed cell death.

Annexin V and Propidium Iodide

During early apoptosis, a phospholipid called phosphatidylserine (PS) flips from the inner to the outer face of the cell membrane before the membrane breaks. Annexin V is a protein that binds PS, so tagging it with a fluorescent label gives you a marker for early apoptosis. Propidium iodide (PI), meanwhile, is a DNA-binding dye that can only enter cells with compromised membranes. By using both stains together and reading the results on a flow cytometer, you can sort cells into three populations: viable (no stain), early apoptotic (Annexin V positive, PI negative), and late apoptotic or necrotic (both positive).¹³

The combination is powerful but has a quirk worth knowing about. Without treating cells with an RNase step, PI can bind to RNA as well as DNA, and up to about 40% of PI-staining events can be false positives. Adding RNase A after a fixation step significantly improves accuracy.¹⁴ Imaging flow cytometry, which captures a picture of each cell as it flows past the detector, adds another layer by letting researchers visually confirm that what the stains indicate matches what the cell actually looks like.¹⁵

Caspase Activation Assays

Caspases are enzymes that execute the apoptotic program by dismantling the cell from the inside. Detecting their activation is strong evidence that a cell has committed to apoptosis. Several methods exist: you can use antibodies that only recognize the active (cleaved) form of a caspase, or you can use synthetic substrates that become fluorescent when a caspase cuts them.¹⁶ Flow cytometry, immunoblotting, and affinity labeling are all used depending on whether you need single-cell resolution or bulk measurement.¹⁷

TUNEL

The TUNEL assay labels broken ends of DNA, which accumulate during apoptosis. It has been a workhorse in histology for decades and remains widely used in tissue sections from animal studies. But there is an important caveat: TUNEL-positive cells are not necessarily dead. Cells in the early stages of apoptosis, and even some in later stages, can reverse course and survive through a process called anastasis. This means that a TUNEL-positive signal in a tissue section may overestimate actual cell death, and the same caution applies to caspase activation readouts.¹⁸

Fluorescence Live/Dead Staining

The calcein-AM/ethidium homodimer dual-stain system provides a visual snapshot of viability in intact tissue or cell cultures. Calcein-AM is a non-fluorescent molecule that enters all cells but only becomes bright green when cleaved by enzymes active in living cells. Ethidium homodimer-1 enters only cells with damaged membranes and binds DNA, producing bright red fluorescence in dead cell nuclei.¹⁹ The result under a fluorescence or confocal microscope is intuitive: green dots are alive, red dots are dead.²⁰

This approach is especially useful when spatial information matters. In a tissue slice, a drug-treated organoid, or a nerve graft, you want to see where the living and dead cells are relative to each other, not just what fraction survived. The pair has been validated across flow cytometry and microscopy platforms, with both methods showing comparable results.²¹

Detecting Ferroptosis

Ferroptosis is a form of regulated cell death driven by iron-dependent accumulation of damaged lipids in the cell membrane. It has become a major research focus in cancer biology and neurodegeneration, and it requires its own detection tools because it does not activate the same caspase or membrane-flipping pathways as apoptosis.

The most common probe is a lipid-soluble fluorescent dye called C11-BODIPY, which shifts its emission wavelength when oxidized. By measuring this shift on a flow cytometer, you can quantify how much lipid peroxidation is occurring in cell membranes.²² Time-course experiments in macrophages showed that a strong, early rise in lipid reactive oxygen species was unique to ferroptosis. Apoptosis and necroptosis both increased general oxidative stress but did not produce a comparable surge in lipid peroxidation.²³ This makes the C11-BODIPY readout a useful way to distinguish ferroptosis from other death modes in the same experiment.

Real-Time and High-Content Imaging

Traditional assays give you a snapshot: cells are alive or dead at the moment you add the reagent. Real-time imaging platforms flip this around by continuously photographing cells inside an incubator and analyzing the images automatically. This captures when each cell dies, not just whether it has.

One common setup uses an incubator-mounted microscope (such as the IncuCyte system) to track fluorescently labeled cancer cells being attacked by immune cells. Cancer cells express a red fluorescent protein so you can count them, and a caspase-3/7 reagent in the medium produces a green signal when apoptosis kicks in. The instrument records images at regular intervals, generating time-lapse data on killing kinetics without anyone opening the incubator lid.²⁴

More elaborate platforms integrate high-content imaging with automated detection of fluorescent death reporters to quantify apoptosis kinetics across large numbers of wells simultaneously, enabling drug screens and genetic screens at a scale that would be impractical with manual endpoint assays.²⁵ The practical benefit is significant: kinetic data reveal whether a drug kills cells quickly or slowly, whether resistant subpopulations emerge over time, and whether apparent survival at a single time point masks delayed death.

Multiplexing and Its Pitfalls

Because no single assay captures every aspect of cell death, researchers increasingly combine (or “multiplex”) several readouts in the same experiment. A typical multiplex design might pair Annexin V staining with a membrane-integrity dye and a caspase reporter, all read on a flow cytometer equipped with multiple lasers. The appeal is efficiency: one sample, three answers.

The catch is that fluorescent dyes can interfere with one another. When you pack multiple fluorescent labels into a single measurement, their emission spectra overlap, requiring careful mathematical correction (called compensation) to tease apart which signal comes from which dye. Without proper single-stain controls, the results become unreliable. There is also a subtler problem: some fluorescent dyes are themselves mildly toxic at higher concentrations or with prolonged exposure, potentially triggering the very oxidative stress or membrane damage you are trying to measure.²⁶ Rigorous controls, including dye-only treated samples, are essential to make sure you are detecting real biology and not an artifact of the measurement itself.

Moving Beyond the Dish

Most cell death assays were designed for cells growing in flat culture dishes. Two frontiers, three-dimensional cultures and living animals, push the limits of standard techniques.

Organoids and 3D Cultures

Organoids are miniature, self-organized tissue structures grown from stem cells. Their three-dimensional architecture makes them more realistic models of human organs, but it also makes them harder to assay. Standard dyes need to penetrate deep into the organoid to reach cells in the center, not just stain the surface. Adapted live/dead kits that use cell-permeant dyes have been shown to penetrate organoids regardless of their size or maturity, producing clear fluorescence signals with minimal background noise. This kind of validation is important because a dye that works perfectly in a flat monolayer can fail completely in a dense spheroid.

In Vivo Probes

Imaging cell death inside a living animal requires probes that can be injected, circulate through the body, and accumulate where cells are dying. Near-infrared fluorescent probes have been developed for this purpose because near-infrared light penetrates tissue better than visible light. One approach uses a zinc-based compound that binds the exposed phosphatidylserine on dying cells, similar in concept to Annexin V but engineered for whole-animal imaging. In mouse models of muscle damage, the probe accumulated at sites of injury, and the signal was confirmed by tissue analysis after sacrifice.²⁷

A more recent design goes further by targeting two apoptosis markers at once: exposed phosphatidylserine and active caspase-3. This dual-targeting probe was used to detect kidney injury in mice as early as 24 hours after treatment with a toxic chemotherapy drug and to track recovery during treatment, providing a longitudinal readout that endpoint assays cannot offer.²⁸ These tools are still largely in the preclinical research phase, but they point toward a future where cell death could be monitored non-invasively in patients.

How the Concept of Cell Death Itself Keeps Expanding

Every assay described above was built to detect a particular molecular event that researchers, at the time, believed defined cell death. The field keeps discovering new exceptions and new forms. The very concept of cell death at the level of individual cells only took shape in the nineteenth century after the development of staining and microscopy, and the term “apoptosis” was not coined until 1972.²⁹ Since then, the catalogue has expanded to include ferroptosis, necroptosis, pyroptosis, and more, each with distinct biochemical triggers. Assay development follows these discoveries: as soon as a new death pathway is defined molecularly, researchers engineer probes and protocols to measure it.

What this means practically is that any “standard panel” of cell death assays has a shelf life. An experiment run five years ago using only Annexin V/PI and MTT would have missed ferroptotic death entirely. Staying current with the nomenclature and with validated assays for newer death modalities is not just an academic exercise. In drug development, misidentifying the type of death a compound induces (or failing to detect that it induces any death at all, as with the MTT artifact described earlier) can send a project down the wrong path. The assay is only as good as the question it was designed to answer, and the questions keep getting more specific.